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Abstract
Global expression analysis of fetal liver hematopoietic stem cells (FL HSCs) revealed the presence of unspliced pre-mRNA for
a number of genes in normal FL HSCs. In a subset of these genes, Crebbp+/2 FL HSCs had less unprocessed pre-mRNA
without a corresponding reduction in total mRNA levels. Among the genes thus identified were the key regulators of HSC
function Itga4, Msi2 and Tcf4. A similar but much weaker effect was apparent in Ep300+/2 FL HSCs, indicating that, in this
context as in others, the two paralogs are not interchangeable. As a group, the down-regulated intronic probe sets could
discriminate adult HSCs from more mature cell types, suggesting that the underlying mechanism is regulated with
differentiation stage and is active in both fetal and adult hematopoiesis. Consistent with increased myelopoiesis in Crebbp
hemizygous mice, targeted reduction of CREBBP abundance by shRNA in the multipotent EML cell line triggered
spontaneous myeloid differentiation in the absence of the normally required inductive signals. In addition, differences in
protein levels between phenotypically distinct EML subpopulations were better predicted by taking into account not only
the total mRNA signal but also the amount of unspliced message present. CREBBP thus appears to selectively influence the
timing and degree of pre-mRNA processing of genes essential for HSC regulation and thereby has the potential to alter
subsequent cell fate decisions in HSCs.
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Introduction
Cyclic-AMP-responsive element binding protein (CREB) bind-
ing protein (CREBBP) – more commonly referred to as CBP – is a
multifunctional protein which facilitates gene expression through
several mechanisms, including chromatin remodeling, acetylation
of associated proteins, and recruitment of the basal transcription
machinery to promoters [1]. We have previously shown that
CREBBP and its paralog EP300 are essential for proper
hematopoietic stem cell regulation but are nevertheless not
functionally redundant in this setting: both copies of Crebbp are
essential for HSC self-renewal while Ep300+/2 HSCs are not
compromised in this respect[2]. Inactivation of a single copy of the
Crebbp gene results in multi-lineage defects in differentiation with a
clear excess in myeloid cell production and an age-dependent
increase in the incidence of hematologic malignancies[3].
CREBBP also acts as a scaffold in numerous protein-protein
interactions [4] so that changes in its levels have the potential to
broadly affect cellular processes by altering multiple signaling and
transcriptional pathways. In particular, it has the potential to act as
a signal integrator within the hematopoietic system[5] through its
interaction with both ubiquitous transcription factors such as
SP1[6,7] and the glucocorticoid receptor (NR3C1) [8,9] and with
factors like SFPI1/PU.1[10] and C/EBPalpha[11] which are
essential for HSC function[12,13].
In addition to its activities as coactivator and integrator,
confocal microscopy studies have localized CREBBP to nuclear
speckles containing splicing proteins[14,15] and it has been shown
to regulate 39-end processing[16]. Both CREBBP and EP300 have
furthermore been shown to be concentrated at both 59 and 39 ends
of genes with which they associate[17]. It thus appears that
CREBBP is involved in pre-mRNA maturation. In addition,
experiments in macrophages[18] and T-cells[19] have shown
CREBBP/EP300 to be present at the promoters of early response
genes, even in the absence of stimulus, and associated with the
production of full-length, unspliced transcripts. Other recent
studies have reported that a large majority of genes with a paused
polymerase produce full-length transcripts, although often at levels
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studies have documented the presence of low-abundance intronic
sequences in B-cell, kidney[21] and embryonic stem cell lines[22].
It has also been noted that HSCs prime multiple lineage programs
prior to commitment decisions[23] and that HSCs normally
contain unspliced transcripts that disappear as HSCs are driven to
proliferate and differentiate[24]. Destabilization of this primed
state has been proposed as a first stage of a cascade towards
differentiation[25]. The general model that emerges from these
findings is that unspliced, full-length transcripts are produced as a
means of bookmarking loci and keeping them in an open
chromatin state to facilitate subsequent rapid transcriptional up-
regulation[18,19].
The presence of unspliced transcripts in HSCs and the links
between CREBBP and EP300 with the constitutive production of
unspliced RNA and with pre-mRNA processing prompted us to
examine more closely an anomaly we had noted in microarray-
based gene expression studies but had previously attributed to
experimental ‘‘noise’’. We had noticed that more than half of the
probe sets down-regulated in Crebbp+/2 FL HSCs relative to wild-
type (WT) mapped entirely within introns, rather than detecting
exonic or spliced sequences. We therefore set out to test whether
this might be evidence that reduced CREBBP levels selectively
alter the generation of full-length, unspliced pre-mRNA. We also
asked whether this process might be associated with differentiation
since self-renewal and lineage commitment are both responses for
which HSCs are primed.
As predicted by our microarray studies, we found that several
genes associated with HSC function showed variable ratios of
intronic to total RNA signal in Crebbp+/2 FL HSCs relative to
WT by quantitative RT-PCR (qRT). In addition to primary FL
HSCs, we looked for CREBBP-associated changes in mRNA,
intronic message and protein levels in multipotent EML cells
which retain lymphoid, myeloid and erythroid potential in the
presence of Stem Cell Factor (SCF) but can be induced to undergo
differentiation by treatment with appropriate stimuli[26]. Target-
ed reduction of Crebbp by shRNA in EML cells was sufficient to
trigger widespread myeloid differentiation of EML cells, bypassing
their usual requirement for withdrawal of SCF and treatment with
retinoic acid, interleukin-3 (IL-3) and granulocyte-macrophage
colony stimulating factor (GM-CSF). A subset of genes tested also
showed altered levels of intronic message in subpopulations of
EML cells at different phenotypically-defined stages of develop-
ment which corresponded to changes in protein abundance not
predicted by full-length mRNA levels. Furthermore, the differ-
ences in intronic levels correlated with differentiation stage-
dependent changes in CREBBP levels. Taken together, our data
suggest a novel, cell type-specific function for CREBBP in
regulating the timing and extent of pre-mRNA splicing of key
regulators of HSC maintenance and function.
Results
Down-regulation of intronic probe sets without
proportional changes in total mRNA levels
We have carried out a global analysis of expression profiles of
WT and Crebbp+/2 FL HSCs. Our in-house annotation of the
Affymetrix Mouse 430 2.0 microarrays (see Materials and
Methods for details) indicated that ,60% of down-regulated
probe sets - but none of the up-regulated ones - mapped on the
coding strand but entirely within intronic regions of genes (Table 1
and Table S1). This is a significant enrichment over the array
background of 15% (6780/45037, excluding Affymetrix control
probe sets, x
2 test p ,1.1610
215). Of the 83 intronic probe sets
representing 77 distinct transcripts (both protein-coding and non-
coding genes), 13 were designed to detect expressed sequence tags
(ESTs) in libraries constructed from adult HSCs[24,27,28]. In
total, there was evidence in the EST database for intronic message
for 50/77 transcripts (Table S1). We will refer to these probe sets
and their associated genes as ‘‘intronic probe sets’’ and ‘‘intronic
targets’’, respectively, to distinguish them from ‘‘mRNA probe
sets’’ and ‘‘exonic probe sets’’ detecting spliced mRNA or 39-most
exons. Notably, of the 74/77 transcripts with both intronic and
mRNA probe sets, we found changes in total mRNA levels for
only 2: Mbnl1 and Meis1. In both cases, the mRNA probe set could
detect either a putative (non-RefSeq) alternative 39 exon or an
intron in a longer isoform.
An attenuated bias was found in an Ep300+/2 FL HSC
expression data set we produced concurrently in which 15/35
differentially expressed probe set were intronic (x
2 test
p=1.3610
25), again all of them down-regulated. In contrast,
probe sets altered in Crebbp+/2 mouse embryonic fibroblasts
(MEFs) relative to WT MEFs showed no enrichment for intronic
probe sets (Table 1), indicating that the effect is cell type-specific.
Like CREBBP, CDKN1A (p21
Cip1/Waf1) is required for HSC self-
renewal and its loss leads to exhaustion of the HSC pool upon
serial transplantation[29]. Unlike Crebbp+/2 FL HSCs, however,
FL HSCs null for Cdkn1a showed both up- and down-regulated
intronic probe sets at a frequency close to predicted relative to
their WT controls (Table 1). The change in intronic sequence
abundance is thus not common to all FL HSCs with compromised
self-renewal ability.
Down-regulated intronic probe sets as a discriminating
HSC signature
To determine whether these differentially expressed intronic
probe sets were functionally relevant, we first asked whether the
intronic probe sets down-regulated in Crebbp+/2 FL HSC could
distinguish HSCs from more mature cell types by hierarchical
clustering. We took advantage of previously published data sets
available for download from the Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo/). In the absence of appropri-
ate data sets from fetal liver, we selected expression series
comparing adult bone marrow (BM) HSCs and various popula-
tions of early progenitors and more mature hematopoietic
cells[30,31,32]. The fetal liver is the primary site of hematopoiesis
from day 11 of mouse development, a function taken over by the
bone marrow after birth[33]. Although FL HSCs are phenotyp-
ically and functionally distinguishable from BM HSCs, FL HSCs
are capable of fully reconstituting long-term hematopoiesis in adult
animals[34,35] and unspliced transcripts had previously been
detected in adult BM[24].
We used either all 83 probe sets for clustering or the single most
highly expressed probe set per transcript (77 in total) to avoid
overweighting genes detected by multiple intronic probe sets. The
cell populations clustered the same way with both approaches.
Figure 1A shows the heat map and sample dendrogram for
GSE6506[31]. The two adult BM HSC (SP-LSK) samples of this
data set are grouped together on a branch (indicated in red)
distinct from all the more differentiated cell types. As a control, we
generated 10,000 random samples of 83 probe sets annotated as
being both intronic and expressed in WT or Crebbp+/2 FL HSCs.
Only 0.52% of the random samples yielded such a clean
distinction of HSCs from mature cell types, arguing against the
separation occurring purely by chance and suggesting that the
underlying process may be common to both adult and fetal HSCs.
Are the intronic probe sets simply surrogate measures of the
total mRNA level? For each gene with at least one mRNA probe
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Crebbp+/2 vs WT FL HSC data set was retained. Figure 1B shows
the heat map for the same genes as 1A and in the same row order
but with the various cell populations clustered by mRNA probe
set. In this case, the HSC branch (shown in red) is no longer clearly
distinct from mature cell types but is part of a subtree including all
lymphoid cell types. Since the two heat maps are row-normalized,
it is clear that the relative expression levels of intronic and mRNA
probe sets for the same gene are often quite different (for example,
compare the relative levels for Mds1, marked by a red asterisk in
both Figure 1A and 1B). This is inconsistent with intronic
transcript levels being a constant proportion of total message
produced in all cell types.
Hierarchical clustering of 2 other publisheddata sets werecarried
outinthesame manner(Figure 1C).Ineachcase,the intronicprobe
sets (Figure 1C left) segregated the experiment’s HSCs (indicated by
red bars) from mature cell types. In addition, hierarchical clustering
using mRNA probe sets (Figure 1B and 1C right) resulted in
somewhat different clustering tree structures than those generated
using intronic probe sets (Figure 1A, 1C left), depending on the
populations involved. Where intronic and mRNA clustering
dendrograms are noticeably different (based on total distance along
the dendrogram arms and positions of branch points), the intronic
probe sets separate HSCs from early progenitors better than do the
mRNA probe sets (shorter overall distance, different branches). The
changes in intron levels are therefore not strictly reflections of those
in total mRNA differences.
Encouraged by this evidence that the presence of unspliced
message was non-random and the finding that our intronic
signature was associated with HSC differentiation, we then carried
out 3 independent qRT experiments in purified FL HSCs with
primers designed to detect spliced or unspliced transcripts
(Table 2). Follow-up targets were selected based on previous
reports of their involvement in HSC function[36,37,38,39,40,41]
or, in the case of Rbpms, for its implication in developmental
processes[42] and physical association with SMAD4[43], a factor
critical for HSC self-renewal[44]. For exonic amplicons, results
from qRT consistently agreed well with the microarray data
(Table S2), showing little if any change between WT and Crebbp+/
2 samples. For intronic amplicons, the reproducibility of the
results depended on the proximity of the amplicon to poly(A) tracts
of sufficient length to potentially prime the oligo(dT) reverse
transcription[45] that we used to amplify our starting material
(Table S2). Despite this technical limitation, we found that Tcf4/
E2-2 and Msi2 intronic amplicons both showed reduced levels in
Crebbp+/2 HSC relative to WT. Two other genes, Itga4 and
Rbpms, which had down-regulated intronic probe sets (although
only to a p-value ,0.1 significance level in the microarray data)
also exhibited greater reduction in intronic than total signal.
Figure 2 shows a summary of these results. Plotted are the ratios of
total mRNA and intronic signal of WT FL HSCs relative to either
Crebbp+/2 (A) or Ep300+/2 (B). Genes for which the ratio is
similar for total mRNA and unspliced transcripts fall between the
vertical and horizontal grey lines marking 1.5-fold differences.
Tcf4, Msi2 and Rbpms, on the other hand, fall within the vertical
lines, indicating similar mRNA levels in WT and Crebbp+/2
HSCs, but lie well above the horizontal line marking a greater
than 1.5-fold excess intronic signal in WT cells. Itga4 mRNA levels
decreased roughly 2-fold in Crebbp+/2 HSCs relative to WT but
unspliced transcript levels are reduced even more substantially
(,10-fold). Consistent with the array data, Ep300+/2 samples
showed attenuated, if any, difference in intronic and total mRNA
ratios (Figure 2B).
Many of our target genes were .100 kilobases long and their
mRNA was detected at modest levels on the microarrays.
Consequently, we wondered whether changes in intronic sequence
detection was a widespread phenomenon and whether it
correlated with transcript length or expression level. We therefore
carried out a further set of qRT reactions using linked primer pairs
for which either the forward or the reverse primer was common to
both the exonic and intronic amplicons for a given gene (see
Table 2 for details). We included genes of varying lengths and
predicted expression levels based on the microarray data.
Figure 2C shows total and intronic mRNA levels for each gene
in WT and Crebbp+/2 HSCs. As can be seen in the figure, not all
transcripts were altered in Crebbp+/2 HSCs (e.g. 170081L11Rik
indicated as ‘‘L11Rik’’). In some cases, both intronic and total
signal changed proportionately (e.g. Dhcr7, Mllt10 where the slope
from the WT square to the Crebbp+/2 circle is close to 1) while in
others the variation was greater in the intronic signal than in total
mRNA level (e.g. Ly6, Pole, Meis1). The change in intronic signal
relative to total message thus seems gene-specific rather than a
function of length or mRNA abundance (compare Ly6E, Igf1R and
Angpt1, for example). Overall, the clustering and qRT results
indicate that the mechanism underlying the alterations in intronic
signal is both cell-type specific and selective in its targets.
Table 1. Distribution of Probe Sets Differentially Expressed Relative to Matched Wild-type Cells.
Crebbp+/2 HSC Ep300+/2 HSC Cdkn1a2/2 HSC Crebbp+/2 MEF
Probe set target Up Down Up Down Up Down Up Down
mRNA
RefSeq 48 27 4 12 5 48 18 33
non-RefSeq* 6 0 1 2 0 1 0 5
ncRNA 0 3 0 0 0 1 0 1
putative ncRNA 1 2 0 0 2 4 0 0
putative alt 39UTR 5 14 0 1 0 3 0 0
Total mRNA 60 46 5 15 7 57 18 39
intronic (expected
{) 0 (15) 83 (15) 0 (3) 15 (3) 3 (7) 15 (7) 0 (5) 1 (5)
repeat 0 6 0 0 0 3 0 0
ambiguous/unclear 1 1 0 0 0 6 0 2
doi:10.1371/journal.pone.0024153.t001
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intronic probe sets
We found no particular gene ontology term or pathway
significantly over-represented among the 77 distinct transcripts
hosting these 83 intronic probe sets. The list of functional
categories represented by their encoded proteins, however,
included kinases as well as genes associated with transcription,
cell cycle regulation and cellular division, growth regulation and
organismal development, chromatin binding and modification,
and RNA binding and processing (Table 3). This last category is
notable as it suggests that CREBBP might indirectly modulate
intronic signal levels by regulating the expression of proteins
that are themselves involved at different stages of RNA
metabolism. Furthermore, CREBBP itself has also been
localized by immunofluorescence to splicing speckles[14,15]
suggesting that it may also play a direct role in the splicing
process. Interestingly, among the non-intronic targets summa-
rized in Table 1 and listed in Table S1 are 2 down-regulated
probe sets that detect the non-coding RNA, Malat1, which is
also associated with splicing speckles[46] and regulates alterna-
tive splicing of pre-mRNA[47]. CREBBP may thus participate
at several levels, both directly and indirectly, in a feed-forward
loop regulating pre-mRNA processing.
We do not see a generalized impact on intronic levels with the
reduction in Crebbp expression, however, indicating that there is
some selectivity in the genes exhibiting these changes. We found
evidence that the promoters of genes with differentially
expressed intronic probe sets are enriched for a different set of
transcription factor binding sites (TFBS) proximal to their
transcription start sites (TSS, -500bp to +250bp) relative to the
exonic target genes (Table 4 and Table S1). TFBS for
ARID3A/BRIGHT, C/EBPalpha, GFI1, IRF1, NR3C1 (glu-
cocorticoid receptor), SOX5 or SOX17 where significantly
enriched only in the intronic target set. At least one of these
TFBS was present in each of the intronic target promoters and
81% of promoters had sites for 3 or more of these transcription
factors, all of which are expressed in FL HSCs based on our
microarray data. Each of these factors except SOX5 has been
implicated in hematopoietic regulation at various stag-
es[13,48,49,50,51,52] and CREBBP has been shown to interact
(directly or by homology with EP300) with C/EBPalpha, IRF1,
NR3C1 and multiple SOX family members[4].
Taken together, these results indicate that reduction in
CREBBP level in HSCs alters pre-mRNA processing in a
regulated manner for a subset of genes. It is difficult to obtain
sufficient material reproducibly from FL or adult HSC for in-
depth molecular analyses so we turned for our subsequent
studies to HSC-like EML cells which possess lymphomyeloid
differentiation potential[26] and have previously been used as a
model system for studying hematopoietic lineage commit-
ment[53,54,55].
Differentiation-associated down-regulation of CREBBP
and spontaneous commitment to myeloid lineages upon
knock-down of Crebbp expression in EML cells
Crebbp expression is widespread but developmentally regulated
during embryogenesis[56] and its transcript[57] and protein levels
(Figure 3A) are lower in certain committed progenitors and
mature cells than in HSCs. Similarly, EML cells driven to myeloid
differentiation by growth factor and all-trans retinoic acid (ATRA)
stimulation down-regulate CREBBP levels (Figure 3B). Parental
EML cells (Figure 3C i) showed a characteristic hand-mirror
morphology that was lost as the cells began differentiating upon
reduction of SCF and addition of IL-3 and ATRA (Figure 3C ii).
As previously reported[53], the shift to medium containing only
GM-CSF resulted in some cell death but cultures further
stimulated with GM-CSF + ATRA gave rise to mature
granulocytes (,70% of cells, Figure 3C iii) mixed with
macrophages (Figure 3C iv).
Cells exposed to control shRNA against GFP continued to
express CREBBP at WT levels (compare Figure 3D EML and
shGFP) and grew in suspension like parental EML cells. In
contrast, reduction of CREBBP levels by lentiviral delivery of
shRNA led to widespread death or stimulus-independent differ-
entiation of EML cells (Figure 3D i–ii).
Forty Crebbp knock-down (shCrebbp) clones were isolated in
SCF-containing methylcellulose and then passaged in liquid
culture in the presence of SCF (i.e. under non-differentiating
conditions). Within 3–4 weeks, 39% of clones were dead or dying,
39% had differentiated and the remainder underwent extensive
cell death before subclones emerged, either looking and growing
like the parental EML cells or else differentiating. Figure 3E shows
growth histories for 37 clones still alive after 40 days. Each point
reflects the state of the culture on the indicated day post-cloning:
‘‘EML-like’’ cells grew rapidly in suspension (,5% adherent, blue
circles), ‘‘mixed’’ cultures contained less than 50% differentiated
(adherent) cells (purple circles), ‘‘differentiated’’ cultures contained
mostly adherent cells (red circles) and ‘‘dying’’ cultures contained a
majority of dead cells (black circles). Clones with lower levels of
Crebbp message (as measured by qRT at week 5) were more likely
to differentiate and eventually die. Clones that survived for the full
length of the experiment (120 days) generally grew in suspension
like parental EML cells and seemed to arise as subclones in
cultures that had undergone substantial cell death. As controls, we
also followed 20 clones receiving control shRNA targeting GFP
and 20 that were cloned but not exposed to virus. All grew like
parental EML cells for more than a month, indicating that
differentiation and death were not predominantly side-effects of
lentiviral treatment or cloning.
Down-regulation of CREBBP in EML cells thus mimics the mix
of cell death and myeloid differentiation seen in these cells when
they are driven to differentiate by ATRA, IL-3 and GM-CSF
stimulation[53], suggesting that CREBBP either acts downstream
Figure 1. Discriminatory power of intronic probe sets in hierarchical clustering of hematopoietic cell populations. (A) Hierarchical
clustering of expression data from Chambers et al[31] using intronic probe sets down-regulated in Crebbp+/2 vs WT HSCs. Cell types represented are
adult HSCs (SP-LSK, red branch on the dendrogram), activated (a) and naive (n) CD4+ and CD8+ lymphocytes, natural killer (NK) cells, B cells,
nucleated erythrocytes (NuclE), monocytes (Mono), and granulocytes (Gran). (B) Same data set as in (A) but with cell populations clustered using
mRNA probe sets for the same target genes. In cases where multiple probe sets were available, the one with the largest difference in Crebbp+/2 vs
WT HSCs was used. Genes are shown in the same order as in (A) with HSC branches shown in red to the nearest junction point with a mature cell type
subtree. (C) Clustering as in (A) (left) and (B) (right) of 2 other published data sets[30,32] with different subpopulations. As before, red dendrogram
branches highlight the distance from HSCs to the nearest mature cell type junction point. LSK: Lin- SCA1+ KIT+; SP: side population; LK: Lin- KIT+;
MEP: megakaryocyte/erythrocyte progenitor, LK SCA1- CD34- Fc-gammaRII/III-; MPP: multi-potential progenitor, LSK CD150- FLT3+; PreMegE:
megakaryocyte/erythrocyte progenitors, LK SCA1- CD150+ CD105- CD41-.
doi:10.1371/journal.pone.0024153.g001
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through an independent, parallel pathway. The spontaneous
myeloid differentiation of EML cells after Crebbp knock-down,
reminiscent of the increased myelopoiesis seen in Crebbp+/2
animals[3], and the differentiation-induced down-regulation of
CREBBP protein levels, similar to that observed in differentiating
hematopoietic cells (Figure 3A and [57]), both indicate that
regulated reduction of CREBBP abundance is a key event in early
hematopoietic differentiation.
Fluctuations in intronic-to-total mRNA ratios and protein
levels in HSC-like EML cells depending on differentiation
stage and CREBBP levels
We had confirmed by qRT that intron levels for Itga4, Msi2 and
Tcf4, each of which has been implicated in hematopoietic
development[38,41,58,59], were reduced in Crebbp+/2 FL HSCs
relative to WT (Figure 2).Wenow wanted to know whether a natural
reduction in CREBBP protein occurring as a consequence of normal
differentiation processes in EML cells would result in similar intronic
changes. More importantly, we wondered whether fluctuations in
intronic levels could have a measurable impact on protein levels.
EML cell cultures kept undifferentiated by the presence of SCF
are a mixture of CD34+, SCF-responsive, replicating cells and their
progeny CD34-, SCF-independent cells that become responsive to
interleukin-3[53]. In addition to HSC-like cells (EML-HSC: Lin-
SCA1+ CD34+ KIT++), the cultures also contain cells which have
cell surface marker profiles similar to early myeloid progenitors
(EML-CMP/GMP: Lin- SCA1- CD34+ KIT++) and megakaryo-
cytic-erythroid progenitors (EML-MEP: Lin- SCA1- CD34-
KIT++). Down-regulation of CREBBP abundance can be seen in
phenotypically distinct subpopulations of EML cells (Figure 4A,
inset). In particular, EML-MEP have roughly 50% of EML-HSC
CREBBP protein levels,muchlikeprimary BM MEPs do relative to
HSCs (Figure 3A). In each case, protein levels were lowest in EML-
MEPs (Figure 4A). Relative mRNA and intronic signals varied by
target and cell subpopulation but, again, changes were most
pronounced in EML-MEPs (Figure 4B).
Table 2. Primer Sequences Used in qRT Reactions.
Gene Amplicon Type Forward (59-.39) Reverse (59-.39)
Crebbp exonic AAGTCACCCAGCTCTCCTCA GGCTGATTGGCCACATACTT
Ep300 exonic GCCTTCTCCACACCATGTTT CGAGCTGTGAAAGCATTGAA
Gapdh exonic ACGTGCCGCCTGGAGAA CATGCCTGCTTCACCACCTT
Ly6E intron-spanning CTTCCAACATGAGAGTCTTCC GCAGATAACGTGATACAGTAATGG
exon-intron GTTGTCATTGGCTGGCTTTT GCAGATAACGTGATACAGTAATGG
1700081L11Rik intron-spanning AAGCGTTTGATTCGGATGTC CTGTTGTATGATCTGGGAAAGG
exon-intron AAGGGAAAGGCCTCTGGTTA CTGTTGTATGATCTGGGAAAGG
Dhcr7 intron-spanning GATTGTAGCCTGGACCCTCA GAGAGCTGCACAGGGTGGTA
exon-intron GAAGCTGGCGTGACAAGTCT GAGAGCTGCACAGGGTGGTA
Pole intron-spanning CTGATGGCCTTCACACTTCA CTTTTGGAGCAGGCAGTAGG
exon-intron CTGATGGCCTTCACACTTCA TGCTCTGCTCCTGCACTCTA
Mllt10 intron-spanning TTCCATGCAGTATCGACATGA TGACCAGATGACTGCTGAGG
exon-intron AGGGAAGGGATCAAGGAGAA TGACCAGATGACTGCTGAGG
Igf1r intron-spanning AGCCCATGTGTGAGAAGACC ACGCAGGTTGTGTTGTCGT
exon-intron AGCCCATGTGTGAGAAGACC CGGAGCAGAAAGTGGAAGTC
intronic GTTGTGCCCCAGTGTTTTCT TGGTCCTCAGCCAAGAGACT
Angpt1 intron-spanning TCTGCCAGCTGTGTCTTGTT CGTGTGGTTTTGAACAGCAT
exon-intron TCTGCCAGCTGTGTCTTGTT CGTGTGGTTTTGAACAGCAT
exonic GCGCTGGCAGTACAATGACAGTTT CACATTGCCCATGTTGAATCCGGT
intronic ACAACAGAGGCCACAAGCCTTAGA CACCAGCCACTGCACAAAGACATT
Meis1 intron-spanning ACAATTTCTGCCACCGGTAT GTTCCTCCTGAACGAGTGGA
exon-intron CCCTGTAGCCCTCCTCAGTT GTTCCTCCTGAACGAGTGGA
exonic TAGGAGGAGGCATGGAAACCCAAA AGGTGATGGTTGTTGTTGCATGGG
intronic TGTGGTCCTATTTGCCCACTGCTA TGCAACTCCATCCTCTGACACCTT
Tcf4 exonic AGGACGAAATGCTGACCCTGAAGT CGGGCAATGCTGCATGTAATTCCT
intronic AACTCCCGTGGGAATGAGTGATGT ATGCCCACTGCCAACATCATGAAC
Msi2 exonic TGGTACTTAAGGCACAGCCAGTGT TTCTGCGCTATCCCGTCTGTGAAT
intronic TGCAGAAGCCAGCAAGTAGACTGT AGGACTCGCTAGCCAAGATGGTTT
Rbpms exonic GGCAAACACGAAGATGGCCAAGAA TATGGCTCCCTGGCAATGAACTGA
intronic AGGTTCCTGCCAATCCTGTCCTTT AAACTGTGCTGCAAGGGTTCCAAG
Itga4 exonic AGACCTTTGTACCTTTGCCTCCCA AGAGAGAGCCTTCCCTGTTTGCTT
intronic GCAGGACATTCAAGTTGCCCTTGT AGGAATTCCCACCTGCTACCAACA
doi:10.1371/journal.pone.0024153.t002
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production of unspliced, full-length transcripts can represent a
sufficiently large proportion of the total mRNA pool to have a
detectable impact on protein levels. Figure 4C shows a cartoon of
scenarios in which relative protein abundance and total mRNA
levels would not correlate well. In each case illustrated (X, Y and
Z), the same full-length mRNA signal is present (as detected by
qRT, for example, by a 39 exonic probe indicated by the magenta
spots). However, varying levels of unspliced transcript detected by
an intronic probe (yellow spots) would result in different protein
levels since only fully processed mRNA can be translated. In the
absence of some correction for the presence of unspliced
transcripts, a comparison of full-length message levels in X, Y
and Z would thus predict lower than observed protein levels for Y
relative to X or, conversely, higher than observed protein levels in
Z relative to X.
Our data show instances of each of these cases. Full-length
transcript levels of Itga4 in EML-HSCs are on average lower than
in EML-MEPs but protein levels are higher (Figure 4D). Factoring
in intronic signal levels yields a better estimate of protein
abundance. In the case of Msi2 (Figure 4E), the combination of
both lower total mRNA and a greater proportion of unspliced
product in EML-MEPs relative to EML-HSCs results in a more
substantial reduction in protein levels than predicted solely by
relative mRNA levels.
Taken together, these data indicate that the differences in
unspliced pre-mRNA levels we detected originally in FL HSCs are
context-sensitive, varying with both developmental and differen-
tiation stage. More importantly, these changes have the potential
to alter protein levels and, consequently, to have an impact on
downstream HSC functions.
Discussion
The production of mature, fully spliced mRNA is subject to
regulation not only at the initiation stage but also during
elongation, 39-end processing and through splice site selection.
Although there is a preferred order in intron removal, excision
does not necessary proceed in a linear or directional manner[60]
and, in some cases, splicing of one intron can alter subsequent
splice site selection[61,62]. In addition, elongation and splicing are
regulated in a cell type- and differentiation stage-specific
manner[63]. Recent studies in HSCs[24], macrophages[18] and
T-cells[19] have raised the possibility of a further level of control to
this already complex system whereby production of full-length but
unprocessed transcripts can serve to maintain a locus accessible
but non-productive until appropriate signals are received. The role
of CREBBP as a context-dependent transcriptional coactivator or
inhibitor has been known for some time[64,65]. Less familiar are
its function in 39-end processing[16] and its colocalization with
splicing factors and nascent transcripts in nuclear speckles[14,66].
Hargreaves et al. have also recently proposed a role for CREBBP
in macrophages in the production of unspliced mRNA in primary
response genes with GC-rich promoters (so-called PRG-I genes)
[18].
In light of these studies linking CREBBP not only with initiation
of transcription but also with pre-mRNA processing, we set out to
determine whether fluctuations in intronic signals we detected in
microarray studies of Crebbp+/2 FL HSCs were real and might
reveal something novel about the underlying biology of HSCs
beyond what corresponding mRNA levels could tell us. Although
our initial observations came from fetal HSCs, we found that the
same probe set signature could distinguish adult HSC from
differentiated cell types better than non-intronic probes sets for the
same genes. In addition, despite the fact that each independently
published data set we examined had slightly different isolation
procedures for their HSC populations, our intronic signature
Figure 2. Changes in the ratio of unspliced message relative to
total mRNA ratios in WT vs Crebbp+/2 HSCs. (A) WT/Crebbp+/2
ratios for total mRNA vs unspliced mRNA qRT signal for the indicated
genes. Dashed grey lines mark the 1.5-fold limit used as a cut-off for
differential expression. Points lying within the vertical grey lines but
above the horizontal ones indicate little change in mRNA levels in WT vs
Crebbp+/2 cells but a reduction in the ratio of unspliced message.
Plotted are median values with horizontal and vertical lines extending to
indicate median absolute deviation for the mRNA and unspliced ratios,
respectively. (B) WT/Ep300+/2 ratios for total mRNA vs unspliced mRNA
qRTsignalfortheindicatedgenes asin(A)showinglittle ifanydiscrepant
change in total andunspliced transcript levels. (C)Total mRNA vs Intronic
qRT signal for the indicated genes in WT and Crebbp+/2 HSCs. Grey lines
indicate a slope of 1 on the log-log plot and are provided as a visual
reference only. Gene lengths in kilobases (kb) are shown at the right.
doi:10.1371/journal.pone.0024153.g002
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indicating that it reflects functionality rather than a specific cell
surface phenotype.
Reduction in CREBBP levels did not result in a generalized
defect in splicing, however. In fact, for most of the transcripts we
tested by qRT, the level of intronic signal tracked with changes in
total mRNA levels so that the proportion of unspliced message
remained constant regardless of expression level. Nevertheless, in
both FL HSCs and phenotypically immature EML cell subpop-
ulations, there was a subset of genes that deviated from this linear
relationship. Our results in FL HSCs had suggested that reduced
levels of CREBBP triggered increased splicing since altered
intronic probe sets were invariably down-regulated but results
with EML cells indicate that, like other mechanisms regulating
pre-mRNA production and maturation, the process (or combina-
tion of processes) we are detecting varies by target gene, cell type
and differentiation state.
A further indication that the changes in intron levels we found
in FL HSCs are functionally relevant is the fact that the
transcription factor binding sites enriched in the proximal
promoter regions of intronic genes were in part different from
those for genes in which total mRNA abundance changes. Binding
sites for SOX17, a factor essential for fetal but not adult
hematopoiesis[52], were over-represented only in intronic targets.
Also selectively enriched in intronic target promoters were binding
sites for interferon-responsive factor 1 (IRF1) and the glucocor-
ticoid receptor (NR3C1). Interferon alpha has been shown to
trigger HSC cycling[67] and IRF1 and NR3C1 exhibit synergistic
or inhibitory crosstalk in signal transduction depending on cellular
context[68,69]. One further tantalizing connection is that mice
haploinsufficient for Crebbp expression develop myelodysplastic
disease within their first year of life (manuscript submitted) and
IRF1 has also been implicated in the pathophysiology of immune-
mediated marrow failure in myelodysplastic syndrome[70] and is
frequently deleted in 5q- myelodysplasia[71].
Interestingly, binding sites for the Ets family factors SFPI1/
PU.1, ETS1, GABPA and ELK1 were enriched in down-regulated
intronic targets and in the up-regulated mRNA set but not in
down-regulated mRNA targets. This shared regulation by up-
regulated mRNAs and transcripts with reduced intronic levels
would make sense if, as our data suggests, a reduction in intronic
signal results in greater mRNA splicing leading to increased
protein production. Shared promoter elements would thus allow
coordinated expression by directly up-regulating transcription for
some targets while increasing the processing of unspliced
transcripts for others. This partitioning of transcription factor
binding site clusters between intronic and mRNA targets is worthy
of further study as it points to specific regulatory modules
participating in CREBBP-mediated control of mRNA processing.
It is still unclear whether the link between altered intronic signal
and differentiation is causative but what is clear from our data is
that knocking down Crebbp expression pushes multipotent EML
cells to commit to myelopoiesis. The HSC-like EML cell line was
established by introducing a dominant-negative retinoic acid
receptor (RARa403) into mouse BM. Due to an RARa403 block,
EML cells require treatment with ATRA to restore their ability to
produce granulocyte-macrophage progenitors (CFU-GM) in
response to IL-3 and GM-CSF[26]. Targeted reduction of Crebbp
expression levels, however, allowed EML cells to bypass this block
and differentiate into macrophages even in the presence of SCF
doses normally able to maintain the cells in an undifferentiated
state. This spontaneous myeloid differentiation of EML cells after
Crebbp knock-down is reminiscent of the increased myelopoiesis
seen in Crebbp+/2 animals[3] and the differentiation-induced
down-regulation of CREBBP protein levels is similar to that we
observed in differentiating hematopoietic cells.
We have shown here that both splicing changes and
spontaneous myeloid differentiation are sensitive to CREBBP
dosage and selective alterations in abundance of intronic
sequences correlate with differentiation in EML cells and changes
in protein levels. Splicing changes varied by cell type and gene but
nevertheless appear regulated as opposed to being a surrogate
measure of total mRNA. Our data are consistent with a
bookmarking model of HSC lineage priming with CREBBP
involved in multiple steps of the lineage decision-making process as
coactivator of transcription and coregulator of pre-mRNA
processing. They also fit well with the concept that key regulators
such as CREBBP can alter the landscape of HSC fate
decisions[25] by altering the probability of adopting a given path
towards self-renewal, death or differentiation.
Materials and Methods
Animals
Mice were bred and maintained under pathogen-free conditions
at the animal facility of the GCCRI. All animal procedures were
approved by the University Health Science Center Institutional
Animal Care and Use Committee (protocol numbers 06030 and
06059). Crebbp+/2 and Ep300+/2 mice (kindly provided by Dr.
D. Livingston, Dana-Farber Cancer Institute, Boston, MA) are
fully back-crossed on a C57BL/6 background. WT littermates
Table 3. Functional Annotation of Intronic Target Genes.
Cell cycle & division AHCTF1 Kinase activity CENTB1
CCND3 IGF1R
MACF1 MAPK6
MAPK6 PCTK2
RIF1 TLK1
TLK1 TNIK
TRIO
Chromatin binding ARID4B RNA binding & AHCTF1
& modification CBX5 processing DGCR8
DNMT3B MBNL1
EPC1 MSI2
JMJD1C PAN3
MBDT1 PRPF40A
TLK1 RBM39
UTX SFRS12
SMG7
Development &
growth
AHCTF1
ANGPT1
MBNL1
MEF2C
MEIS1
RTN4
SPATA5
TCF4
TCF12
doi:10.1371/journal.pone.0024153.t003
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tm1Tyj/J mice and B6129SF2
WT controls were purchased from Jackson Laboratories (Bar
Harbor, ME).
Isolation of FL HSCs and MEFs
Mated females were checked daily for the presence of vaginal
copulation plugs, which defined day 0.5 of gestation. Plugged
females were sacrificed on day 14.5 of gestation and their embryos
harvested. The average cell count of 21 WT fetal livers (14 litters)
was 21.364.1610
6 cells, indicating that the embryos were at a
similar stage of development when sacrificed[72].
FL HSCs. Single cell suspensions were prepared from each
FL and viably frozen. Once enough embryos of each genotype
were collected, cells were thawed and prepared for HSC isolation.
Lineage negative (Lin-: Ter119-, CD5- or CD4-CD8-, B220-,
GR1-) SCA1+ AA4.1+ KIT++[73] cells were purified by
fluorescence-activated cell sorting on a FACSAria (BD
Biosciences, San Jose, CA).
MEFs. Day 14.5 post-coitus embryo bodies were
disaggregated in 0.25% trypsin and plated in MEF medium
(DMEM, 15% FBS, 2mM glutamine, 100 mM non-essential
amino acids, 8.9610
25M b-mercaptoethanol, penicillin/
streptomycin; Invitrogen, Carlsbad, CA).
Microarray analysis
All data is MIAME-compliant and the arrays are available for
download from the Gene Expression Omnibus (GSE27987). For
each HSC sample, 12 ng of RNA were amplified using the
Ovation RNA amplification kit (NuGen Technologies, Inc., San
Carlos, CA). MEF RNA was isolated using TRIzol (Invitrogen)
and used without amplification. After biotin labeling, samples were
hybridized to Affymetrix Gene Chip Mouse Genome 430 2.0
microarrays. Each microarray was checked for large-scale defects,
RNA degradation and the proportion of probe sets called
‘‘Present’’ or ‘‘Absent’’ using MAS5 (,50% in all cases). All
arrays were comparable and satisfactory by these metrics. Arrays
for each group were normalized and corrected for background
using the Bioconductor[74] gcrma package. We excluded from
further consideration probe sets for which all samples in a group
were called ‘‘Absent’’, for which all samples had intensities below
log2 (100) or for which the interquartile range was ,0.5. In the
case of Crebbp+/2, Ep300+/2 and their WT control FL HSCs,
the values of the technical replicates were averaged prior to
filtering based on minimum intensity levels and variation. Paired
Student T-tests with p-value ,0.05 and a fold-change .1.5 were
used as the cut-off for calling significant change.
Annotation
Probe sets on the arrays used in these studies typically comprise
11 25-mers designed to interrogate GenBank mRNA and EST
sequences. We used Blast[75] to map the individual 25-mers for
each probe set to mouse RefSeq mRNA sequences (May 2009).
Probe sets that did not match reference mRNA sequences were
then aligned to genomic sequences corresponding to RefSeq genes
(all bases between the 59-most transcription start site and the 39-
most end position) based on Mouse genome Build 37 (Mm9, July
2007). In both cases, a probe set was called a match if at least 8/11
25-mers aligned perfectly.
Table 4. Binding Sites for Expressed Transcription Factors Enriched in Proximal Promoters of Target Genes.
Intronic (all down) Down mRNA Up mRNA
N=85, 61% (G+C) n=48, 59% (G+C) n=55, 60% (G+C)
Enrichment
P-value
Enrichment
P-value
Enrichment
P-value
Jaspar
TFBS Matrix Factor
Binds CREBBP?
{ Score * TSS Chr19 Score TSS Chr19 Score TSS Chr19
MA0079.2 SP1 Y 110 0.005 0
MA0080.2 SFPI1/PU.1 Y 56.4 0 0 37.7 0 0
MA0152.1 NFATC2 Y 44.5 0.008 0.002 35.1 0 0
MA0098.1 ETS1 Y 25.9 0 0 19.6 0 0
MA0050.1 IRF1 Y 20.2 0 0
MA0113.1 NR3C1/GR Y 20.2 0 0
GFI1_Q6 # GFI1 11.2 0 0
MA0151.1 ARID3A 8.88 0 0
MA0028.1 ELK1 Y 8.82 0 0 2.42 0.006 0.001 13.6 0 0
MA0062.2 GABPA Y 6.81 0 0 15.7 0 0
MA0078.1 SOX17 6.39 0 0.001
MA0108.2 TBP Y 5.63 0.002 0
MA0087.1 SOX5 5.61 0.001 0
MA0102.2 CEBPA Y 4.73 0.001 0
MA0060.1 NFYA Y 10.5 0.001 0 6.4 0.004 0
MA0018.2 CREB1 Y 1.93 0.001 0
{Bedford et al. (2010) and references therein.
*Scores comparable within but not between groups.
#From Transfac; Matys et al. (2003).
doi:10.1371/journal.pone.0024153.t004
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PLoS ONE | www.plosone.org 9 August 2011 | Volume 6 | Issue 8 | e24153Figure 3. Knock-down of CREBBP levels triggers stimulus-independent myeloid differentiation of EML cells. (A) Western blots for
CREBBP in lysates from 15,000 sorted hematopoietic cells per lane for a single experiment. Sort phenotypes: CD34-=LT HSCs (Lin- SCA1+ KIT++ CD34-),
CD34+=ST-HSC (Lin- SCA1+ KIT++ CD34+), MEP= (Lin- SCA1- KIT+ CD34- CD16/32-), GMP= (Lin- SCA1- KIT+ CD34+ CD16/32+), CMP= (Lin- SCA1- KIT+
CD34+ CD16/32-), others as indicated. (B) Western blots for CREBBP in 12.5 mg of nuclear extracts of undifferentiated EML cells (EML) and EML cells
inducedto differentiateby reducingthedose of SCFandadditionof IL3andATRA (lowSCF+IL3+ATRA),switchingtoGM-CSFonly(GM) andthenadding
ATRA (GM+ATRA). Shown is a representative of at least 3 experiments. (C) Depiction of factors required to either maintain undifferentiated EML cell
cultures (SCF) or to trigger myeloid differentiation (IL-3, ATRA, GM-CSF). Vertical red lines indicate RARa403 blocks to differentiation andthe factors used
toovercomethem.(i-iv)RepresentativecytospinsstainedwithWright-Giemsa.(i)UndifferentiatedEMLcellswithcharacteristichand-mirrormorphology.
(ii) EML cells in low SCF + IL-3 + ATRA. (iii, iv) Fully differentiated EML cells after culture in GM-CSF alone followed by GM-CSF + ATRA. (D) CREBBP protein
levels in 3610
5 cloned cells, either control (EML, shGFP) or in representative clones expressing shRNA against Crebbp measured at the indicated times
post-cloning. (i, ii) Representative cytospins of cultures treated with shCrebbp. Scale bar in cytospins =10 mm at 60X magnification. (E) Summary of
outcomes for clones expressing shRNA against Crebbp. Each point represents the state of the culture at the indicated time. Relative Crebbp levels
measured at 5 weeks post-cloning are indicated by the histogram on the left. Growth characteristics are indicated by color: EML-like (rapid growth with
,5% adherent cells), mixed (,50% adherent), differentiated (.50% adherent), dying (.50% cells dead). Clone histories were recorded for 120 days or
ended when the clone could no longer be passaged.
doi:10.1371/journal.pone.0024153.g003
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Data sets of hematopoietic populations using the same microarray
platform as our studies were downloaded from the Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo/) and either repro-
cessed from image files (GSE17765[30], GSE6506[31]) or the
normalized data used as published (GSE18669[32]). Two sets of
probe sets were used for clustering subpopulations: (a) intronic probe
sets differentially expressed in Crebbp+/2 vs WT HSCs and (b) the
most variable mRNA probe set for each gene corresponding to an
intronic probe set in (a). GenePattern[76] was used for hierarchical
clustering and visualization. For randomization studies, the hclust and
cutree functions from the R stats package[77] were used to generate
dendrograms of Pearson correlations and determine the separation of
HSCs from other cell types for 10,000 random samples of expressed
intronic probe sets.
Gene set overlap and TFBS analysis
Gene lists were submitted to web-based MSigDB[78] and
DAVID[79,80] applications and related or overlapping terms
collapsed for simplicity of presentation. Vertebrate position-specific
weight matrices were downloaded from JASPAR[81] and supple-
mented with Transfac[82] matrices for GFI1 and LEF1. These were
Figure 4. Regulated changes in protein levels and intronic sequence abundance as a function of differentiation stage. (A)
Quantification of expression levels for the indicated proteins in phenotypically HSC-like cells (EML-HSC: Lin- SCA1+ CD34+ KIT++), early myeloid
progenitors (EML-CMP/GMP: Lin- SCA1- CD34+ KIT++) and megakaryocyte/erythrocyte progenitors (EML-MEP: Lin- SCA1- CD34- KIT++). Bars indicate
means + SEM of 4 independent experiments normalized to beta-actin levels. Significant differences in protein levels between cell types indicated by *
for ANOVA p-values ,0.05 and ** for ,0.01. Inset: representative Western blots. (B) Full-length vs intronic qRT signals for the indicated genes in the
EML subpopulations described in A. Shown are median values from 3 independent experiments. (C) Model of the potential impact of varying intronic
levels for a constant level of full-length mRNA. Exonic sequences are represented by black rectangles and introns by blue lines. Probes for intronic
and full-length sequences are indicated by yellow and magenta circles, respectively. For each of X, Y and Z, the full-length level is the same (5
magenta circles) but the proportion of unspliced transcript varies (X=2 probes, Y=1 and Z=4). The corresponding protein levels (pink blobs) reflect
the relative proportion of spliced and unspliced transcript since only the latter can be translated. (D) Ratio of full-length mRNA (black box, F), full-
length/unspliced (blue box, F/U) and protein (red box, P) in EML-HSC relative to EML-MEP for Itga4 (E) As in (D) but for Msi2 in EML-MEP vs EML-HSC.
Whisker plots in (D) and (E) show median (line inside box), interquartile range (limits of the box) and data range (limits of whiskers).
doi:10.1371/journal.pone.0024153.g004
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proximal promoters extending 500bp upstream and 250bp down-
stream of the transcription start site (TSS). We used two backgrounds
to correct for compositional biases: one comprising 5Kb regions
centered on all RefSeq (May 2008 download) and another consisting of
mouse chromosome 9. Background sequences were derived from
mouse NCBI Build 37 (Mm9). Results for intronic vs exonic targets
were compared to identify TFBS uniquely enriched in intronic targets.
EML cell culture and differentiation
EML cells (EML clone 1, CRL-11691) were obtained from ATCC
(Manassas, VA). Cells were cultured in IMDM medium supple-
mented with 20% FBS (06952; StemCell Technologies, Vancouver,
BC, Canada) and rmSCF (100ng/ml, R&D Systems, Minneapolis,
MN) to maintain them in an undifferentiated state (non-differenti-
ation medium, NDM). Myeloid differentiation was induced by a 3-
step protocol adapted from a previous study[26]. Briefly, on day 1
cells were switched fromNDM to IMDMplus20%FBSwith alower
dose of rmSCF (50 ng/ml), 25 ng/ml IL-3 (R&D Systems) and
10 mM all-trans retinoic acid (ATRA; R2625, Sigma, St Louis, MI).
On day 4, the medium was replaced with fresh medium containing
onlyGM-CSF(25 ng/ml)and7dayslater10 mM ATRA was added.
shRNA-mediated knock-down of CREBBP in EML cells
A lentivirus-encoded shRNA targeting the sequence 59-CAAG-
CACTGGGAATTCTCT-39 in mouse Crebbp (shCrebbp) was
created by cloning oligonucleotides into the FSIPPW vector as
previously described[84]. A control lentiviral shRNA targeting
enhanced green fluorescent protein (shGFP, 59-AAGAACGG-
CATCAAGGTGAACTT-39) was generated similarly. Both were
packaged as previously described[85]. Co-transfection of 293TD
cells was performed using Lipofectamine 2000 according to
manufacturer’s instructions (Invitrogen). Undifferentiated, early
passage EML cells were split one day prior to infection. Virus-
containing supernatant supplemented with 8 mg/ml protamine was
added to the cells for ,16 hours after which the cells were placed in
fresh NDM. A second round of infection was performed ,8 hours
later using a flow-through infection protocol[86]. Culture medium
was replaced with fresh NDM supplemented with puromycin
(3 mg/ml) the following day to select for transduced cells. Surviving
EML cells were cloned in NDM methylcellulose plus puromycin
(M3234, StemCell Technologies) for 8 days, after which individual
clones were picked and expanded in liquid NDM.
EML subpopulation isolation
Phenotypically primitive EML subpopulations[53] were purified by
f i r s tr e m o v i n gB 2 2 0 +,C D 1 9 +and Ter119+cells by magnetic separation
(Miltenyi, Auburn, CA) and then incubating with SCA1-biotin, followed
by streptavidin-APC-Cy7 and CD34-FITC (BD Biosciences). No anti-
KIT antibody was necessary since all B220- CD19- Ter119- cells were
KIT++. 7-Aminoactinomycin D (BD Biosciences) was used to exclude
dead cells. Purification was done on a FACSAria (BD Biosciences).
Quantitative RT-PCR
Total RNA from cloned EML cells was isolated by TRIzol
extraction and purified with the Qiagen RNeasy kit (Qiagen,
Valencia, CA). Total RNA from all other samples was extracted
using the Qiagen RNeasy (Plus) Micro Kit as directed by the
manufacturer. RNA was then reverse transcribed using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosciences,
Foster City, CA). FL HSC was amplified using the Ovation RNA
amplification kit. PCRwas performed usingeither the SYBR Green
PCR kit (Qiagen) or the GoTaq qPCR Master Mix (Promega,
Madison, WI) on a 7500 Real-Time PCR System (Applied
Biosciences). Data were analyzed using the 2
2DDCt relative
quantification method[87] and normalized to Gapdh. Primers were
designed using the Primer3 web interface[88] (http://frodo.wi.mit.
edu/primer3/). See Table 2 for primer sequences.
Western blots
Anti-CREBBP antibody AC26[89] was kindly provided by Dr
D. Livingston and anti-EP300 antibody RW128 was purchased
from Upstate Biotechnology, Lake Placid, NY. Antibodies against
ITGA4 (Ab65984), MSI2 (Ab76148), TCF4 (Ab72586) and
ACTB (Ab6276) were purchased from Abcam (Cambridge,
MA). Visualization of proteins was done by staining with a goat
anti-mouse or goat anti-rabbit HRP (Bio-Rad Laboratories,
Hercules, CA), as appropriate, and Pierce ECL Western Blotting
Substrate (Thermo Scientific, Rockford, IL) or Amersham ECL
Plus (GE Healthcare, Piscataway, NJ).
Hematopoietic cells. Whole cell lysates from 15,000 cells of
each phenotype were suspended in RIPA buffer containing
protease inhibitors (Roche Diagnostics, Indianapolis, IN) and
PMSF (Sigma-Aldrich, St. Louis, MO) then loaded in each well
after heat denaturation (10 min @ 70uC).
EML cells. Whole cell lysates from 4–5610
5 cells suspended
in RIPA buffer with protease inhibitors and PMSF or 12.5 mgo f
nuclear extracts were loaded per well, as indicated.
Image quantification and statistics. In all cases, ImageJ
software(http://rsb.info.nih.gov/ij) w asusedtoqua nt ifybandint ensit ies.
Significance levels for the differences between cell types were determined
by correlated-samples one-way ANOVA and Tukey HSD test using the
web-based calculator at VassarStats: Website for Statistical Computation
(http://faculty.vassar.edu/lowry/anova1u.html).
Supporting Information
Table S1 Annotation of Differentially Expressed Probe
Sets in Crebbp+/2 vs WT HSCs. Detailed Excel table of
differentially expressed probe sets including EST support for
intronic sequences and expression levels for mutant and WT HSCs.
(XLS)
Table S2 Quantitative RT-PCR Validation of Microar-
ray Results. Detailed Excel table of locations of primer
sequences relative to microarray probe sets and qRT validation
results for exonic and intronic targets. For intronic probe sets, the
table also includes the length of potential poly(A) RT priming sites
and predicted presence of intronic poly(A) signals.
(XLS)
Acknowledgments
The authors thank the GCCRI Laboratory Animal Resources for care of
experimental animals and Karla Moncada of the UTHSCSA Flow
Cytometry Core and Jennifer Rebeles of the GCCRI Shared Instrumen-
tation Facility for assistance with FACS sorting and analysis.
Author Contributions
Conceived and designed the experiments: MEL VIR. Performed the
experiments: ZC QZ RW. Analyzed the data: MEL JC ALK VIR.
Contributed reagents/materials/analysis tools: MEL ALK VIR. Wrote the
paper: MEL VIR.
Role of CREBBP in Pre-mRNA Processing
PLoS ONE | www.plosone.org 12 August 2011 | Volume 6 | Issue 8 | e24153References
1. Kalkhoven E (2004) CBP and p300: HATs for different occasions. Biochem
Pharmacol 68: 1145–1155.
2. Rebel VI, Kung AL, Tanner EA, Yang H, Bronson RT, et al. (2002) Distinct
roles for CREB-binding protein and p300 in hematopoietic stem cell self-
renewal. Proc Natl Acad Sci U S A 99: 14789–14794.
3. Kung AL, Rebel VI, Bronson RT, Ch’ng LE, Sieff CA, et al. (2000) Gene dose-
dependent control of hematopoiesis and hematologic tumor suppression by
CBP. Genes Dev 14: 272–277.
4. Bedford DC, Kasper LH, Fukuyama T, Brindle PK (2010) Target gene context
influences the transcriptional requirement for the KAT3 family of CBP and
p300 histone acetyltransferases. Epigenetics 5: 9–15.
5. Blobel GA (2000) CREB-binding protein and p300: molecular integrators of
hematopoietic transcription. Blood 95: 745–755.
6. Liu Z, Simpson ER (1999) Molecular mechanism for cooperation between Sp1
and steroidogenic factor-1 (SF-1) to regulate bovine CYP11A gene expression.
Mol Cell Endocrinol 153: 183–196.
7. Hauses M, Tonjes RR, Grez M (1998) The transcription factor Sp1 regulates the
myeloid-specific expression of the human hematopoietic cell kinase (HCK) gene
through binding to two adjacent GC boxes within the HCK promoter-proximal
region. J Biol Chem 273: 31844–31852.
8. Almlof T, Wallberg AE, Gustafsson JA, Wright AP (1998) Role of important
hydrophobic amino acids in the interaction between the glucocorticoid receptor
tau 1-core activation domain and target factors. Biochemistry 37: 9586–9594.
9. von Lindern M, Zauner W, Mellitzer G, Steinlein P, Fritsch G, et al. (1999) The
glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to
enhance and sustain proliferation of erythroid progenitors in vitro. Blood 94:
550–559.
10. Yamamoto H, Kihara-Negishi F, Yamada T, Hashimoto Y, Oikawa T (1999)
Physical and functional interactions between the transcription factor PU.1 and
the coactivator CBP. Oncogene 18: 1495–1501.
11. Kovacs KA, Steinmann M, Magistretti PJ, Halfon O, Cardinaux JR (2003)
CCAAT/enhancer-binding protein family members recruit the coactivator
CREB-binding protein and trigger its phosphorylation. J Biol Chem 278:
36959–36965.
12. Iwasaki H, Somoza C, Shigematsu H, Duprez EA, Iwasaki-Arai J, et al. (2005)
Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic
stem cells and their differentiation. Blood 106: 1590–1600.
13. Zhang P, Iwasaki-Arai J, Iwasaki H, Fenyus ML, Dayaram T, et al. (2004)
Enhancement of hematopoietic stem cell repopulating capacity and self-renewal
in the absence of the transcription factor C/EBP alpha. Immunity 21: 853–863.
14. Bex F, Yin MJ, Burny A, Gaynor RB (1998) Differential transcriptional
activation by human T-cell leukemia virus type 1 Tax mutants is mediated by
distinct interactions with CREB binding protein and p300. Mol Cell Biol 18:
2392–2405.
15. McManus KJ, Stephens DA, Adams NM, Islam SA, Freemont PS, et al. (2006)
The transcriptional regulator CBP has defined spatial associations within
interphase nuclei. PLoS Comput Biol 2: e139.
16. Shimazu T, Horinouchi S, Yoshida M (2007) Multiple histone deacetylases and
the CREB-binding protein regulate pre-mRNA 39-end processing. J Biol Chem
282: 4470–4478.
17. Ramos YF, Hestand MS, Verlaan M, Krabbendam E, Ariyurek Y, et al.
Genome-wide assessment of differential roles for p300 and CBP in transcription
regulation. Nucleic Acids Res 38: 5396–5408.
18. Hargreaves DC, Horng T, Medzhitov R (2009) Control of inducible gene
expression by signal-dependent transcriptional elongation. Cell 138: 129–145.
19. Byun JS, Wong MM, Cui W, Idelman G, Li Q, et al. (2009) Dynamic
bookmarking of primary response genes by p300 and RNA polymerase II
complexes. Proc Natl Acad Sci U S A 106: 19286–19291.
20. Core LJ, Waterfall JJ, Lis JT (2008) Nascent RNA sequencing reveals
widespread pausing and divergent initiation at human promoters. Science
322: 1845–1848.
21. Sultan M, Schulz MH, Richard H, Magen A, Klingenhoff A, et al. (2008) A
global view of gene activity and alternative splicing by deep sequencing of the
human transcriptome. Science 321: 956–960.
22. Cloonan N, Forrest AR, Kolle G, Gardiner BB, Faulkner GJ, et al. (2008) Stem
cell transcriptome profiling via massive-scale mRNA sequencing. Nat Methods
5: 613–619.
23. Hu M, Krause D, Greaves M, Sharkis S, Dexter M, et al. (1997) Multilineage
gene expression precedes commitment in the hemopoietic system. Genes Dev
11: 774–785.
24. Bowman TV, McCooey AJ, Merchant AA, Ramos CA, Fonseca P, et al. (2006)
Differential mRNA processing in hematopoietic stem cells. Stem Cells 24:
662–670.
25. Enver T, Pera M, Peterson C, Andrews PW (2009) Stem cell states, fates, and the
rules of attraction. Cell Stem Cell 4: 387–397.
26. Tsai S, Bartelmez S, Sitnicka E, Collins S (1994) Lymphohematopoietic
progenitors immortalized by a retroviral vector harboring a dominant-negative
retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid
development. Genes Dev 8: 2831–2841.
27. Piao Y, Ko NT, Lim MK, Ko MS (2001) Construction of long-transcript
enriched cDNA libraries from submicrogram amounts of total RNAs by a
universal PCR amplification method. Genome Res 11: 1553–1558.
28. Pritsker M, Doniger TT, Kramer LC, Westcot SE, Lemischka IR (2005)
Diversification of stem cell molecular repertoire by alternative splicing. Proc Natl
Acad Sci U S A 102: 14290–14295.
29. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, et al. (2000)
Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287:
1804–1808.
30. Broske AM, Vockentanz L, Kharazi S, Huska MR, Mancini E, et al. (2009)
DNA methylation protects hematopoietic stem cell multipotency from
myeloerythroid restriction. Nat Genet 41: 1207–1215.
31. Chambers SM, Boles NC, Lin KY, Tierney MP, Bowman TV, et al. (2007)
Hematopoietic fingerprints: an expression database of stem cells and their
progeny. Cell Stem Cell 1: 578–591.
32. Weishaupt H, Sigvardsson M, Attema JL Epigenetic chromatin states uniquely
define the developmental plasticity of murine hematopoietic stem cells. Blood
115: 247–256.
33. Orkin SH, Zon LI (2008) Hematopoiesis: an evolving paradigm for stem cell
biology. Cell 132: 631–644.
34. Rebel VI, Miller CL, Eaves CJ, Lansdorp PM (1996) The repopulation potential
of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult
bone marrow counterparts. Blood 87: 3500–3507.
35. Rebel VI, Miller CL, Thornbury GR, Dragowska WH, Eaves CJ, et al. (1996) A
comparison of long-term repopulating hematopoietic stem cells in fetal liver and
adult bone marrow from the mouse. Exp Hematol 24: 638–648.
36. Hisa T, Spence SE, Rachel RA, Fujita M, Nakamura T, et al. (2004)
Hematopoietic, angiogenic and eye defects in Meis1 mutant animals. EMBO J
23: 450–459.
37. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, et al. (2004) Tie2/
angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the
bone marrow niche. Cell 118: 149–161.
38. Arroyo AG, Yang JT, Rayburn H, Hynes RO (1999) Alpha4 integrins regulate
the proliferation/differentiation balance of multilineage hematopoietic progen-
itors in vivo. Immunity 11: 555–566.
39. Hope KJ, Cellot S, Ting SB, MacRae T, Mayotte N, et al. (2010) An RNAi
screen identifies Msi2 and Prox1 as having opposite roles in the regulation of
hematopoietic stem cell activity. Cell Stem Cell 7: 101–113.
40. Kharas MG, Lengner CJ, Al-Shahrour F, Bullinger L, Ball B, et al. (2010)
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid
leukemia. Nat Med 16: 903–908.
41. Murre C (2005) Helix-loop-helix proteins and lymphocyte development. Nat
Immunol 6: 1079–1086.
42. Song HW, Cauffman K, Chan AP, Zhou Y, King ML, et al. (2007) Hermes
RNA-binding protein targets RNAs-encoding proteins involved in meiotic
maturation, early cleavage, and germline development. Differentiation 75:
519–528.
43. Sun Y, Ding L, Zhang H, Han J, Yang X, et al. (2006) Potentiation of Smad-
mediated transcriptional activation by the RNA-binding protein RBPMS.
Nucleic Acids Res 34: 6314–6326.
44. Karlsson G, Blank U, Moody JL, Ehinger M, Singbrant S, et al. (2007) Smad4 is
critical for self-renewal of hematopoietic stem cells. J Exp Med 204: 467–474.
45. Nam DK, Lee S, Zhou G, Cao X, Wang C, et al. (2002) Oligo(dT) primer
generates a high frequency of truncated cDNAs through internal poly(A)
priming during reverse transcription. Proc Natl Acad Sci U S A 99: 6152–6156.
46. Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB, et al.
(2007) A screen for nuclear transcripts identifies two linked noncoding RNAs
associated with SC35 splicing domains. BMC Genomics 8: 39.
47. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, et al. The nuclear-retained
noncoding RNA MALAT1 regulates alternative splicing by modulating SR
splicing factor phosphorylation. Mol Cell 39: 925–938.
48. Webb CF, Smith EA, Medina KL, Buchanan KL, Smithson G, et al. (1998)
Expression of bright at two distinct stages of B lymphocyte development.
J Immunol 160: 4747–4754.
49. Zeng H, Yucel R, Kosan C, Klein-Hitpass L, Moroy T (2004) Transcription
factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells.
EMBO J 23: 4116–4125.
50. Testa U, Stellacci E, Pelosi E, Sestili P, Venditti M, et al. (2004) Impaired
myelopoiesis in mice devoid of interferon regulatory factor 1. Leukemia 18:
1864–1871.
51. Wessely O, Deiner EM, Beug H, von Lindern M (1997) The glucocorticoid
receptor is a key regulator of the decision between self-renewal and
differentiation in erythroid progenitors. EMBO J 16: 267–280.
52. Kim I, Saunders TL, Morrison SJ (2007) Sox17 dependence distinguishes the
transcriptional regulation of fetal from adult hematopoietic stem cells. Cell 130:
470–483.
53. Ye ZJ, Kluger Y, Lian Z, Weissman SM (2005) Two types of precursor cells in a
multipotential hematopoietic cell line. Proc Natl Acad Sci U S A 102:
18461–18466.
54. Finstad SL, Rosenberg N, Levy LS (2007) Diminished potential for B-lymphoid
differentiation after murine leukemia virus infection in vivo and in EML
hematopoietic progenitor cells. J Virol 81: 7274–7279.
55. Suh HC, Gooya J, Renn K, Friedman AD, Johnson PF, et al. (2006) C/
EBPalpha determines hematopoietic cell fate in multipotential progenitor cells
Role of CREBBP in Pre-mRNA Processing
PLoS ONE | www.plosone.org 13 August 2011 | Volume 6 | Issue 8 | e24153by inhibiting erythroid differentiation and inducing myeloid differentiation.
Blood 107: 4308–4316.
56. Partanen A, Motoyama J, Hui CC (1999) Developmentally regulated expression
of the transcriptional cofactors/histone acetyltransferases CBP and p300 during
mouse embryogenesis. Int J Dev Biol 43: 487–494.
57. Terskikh AV, Miyamoto T, Chang C, Diatchenko L, Weissman IL (2003) Gene
expression analysis of purified hematopoietic stem cells and committed
progenitors. Blood 102: 94–101.
58. Kharas MG, Lengner CJ, Al-Shahrour F, Bullinger L, Ball B, et al. (2010)
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid
leukemia. Nat Med 16: 903–908.
59. Hope KJ, Cellot S, Ting SB, MacRae T, Mayotte N, et al. (2010) An RNAi
screen identifies Msi2 and Prox1 as having opposite roles in the regulation of
hematopoietic stem cell activity. Cell Stem Cell 7: 101–113.
60. Lang KM, Spritz RA (1987) In vitro splicing pathways of pre-mRNAs
containing multiple intervening sequences? Mol Cell Biol 7: 3428–3437.
61. Schwarze U, Starman BJ, Byers PH (1999) Redefinition of exon 7 in the
COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a
form of osteogenesis imperfecta: influence of intron splice order on outcome of
splice-site mutation. Am J Hum Genet 65: 336–344.
62. Schor IE, Rascovan N, Pelisch F, Allo M, Kornblihtt AR (2009) Neuronal cell
depolarization induces intragenic chromatin modifications affecting NCAM
alternative splicing. Proc Natl Acad Sci U S A 106: 4325–4330.
63. Uptain SM, Kane CM, Chamberlin MJ (1997) Basic mechanisms of transcript
elongation and its regulation. Annu Rev Biochem 66: 117–172.
64. Giordano A, Avantaggiati ML (1999) p300 and CBP: partners for life and death.
J Cell Physiol 181: 218–230.
65. Goodman RH, Smolik S (2000) CBP/p300 in cell growth, transformation, and
development. Genes Dev 14: 1553–1577.
66. von Mikecz A, Zhang S, Montminy M, Tan EM, Hemmerich P (2000) CREB-
binding protein (CBP)/p300 and RNA polymerase II colocalize in transcrip-
tionally active domains in the nucleus. J Cell Biol 150: 265–273.
67. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, et al. (2009)
IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458:
904–908.
68. Tliba O, Damera G, Banerjee A, Gu S, Baidouri H, et al. (2008) Cytokines
induce an early steroid resistance in airway smooth muscle cells: novel role of
interferon regulatory factor-1. Am J Respir Cell Mol Biol 38: 463–472.
69. Jiang X, Norman M, Roth L, Li X (2004) Protein-DNA array-based
identification of transcription factor activities regulated by interaction with the
glucocorticoid receptor. J Biol Chem 279: 38480–38485.
70. Voulgarelis M, Giannouli S, Ritis K, Tzioufas AG (2004) Myelodysplasia-
associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin
Invest 34: 690–700.
71. Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, et al. (1993)
Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and
preleukemic myelodysplasia. Science 259: 968–971.
72. Morrison SJ, Hemmati HD, Wandycz AM, Weissman IL (1995) The
purification and characterization of fetal liver hematopoietic stem cells. Proc
Natl Acad Sci U S A 92: 10302–10306.
73. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, et al. (2002) A
stem cell molecular signature. Science 298: 601–604.
74. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004)
Bioconductor: open software development for computational biology and
bioinformatics. Genome Biol 5: R80.
75. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local
alignment search tool. J Mol Biol 215: 403–410.
76. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, et al. (2006) GenePattern 2.0.
Nat Genet 38: 500–501.
77. R Development Core Team (2009) R: A language and environment for
statistical computing. ViennaAustria: R Foundation for Statistical Computing.
78. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005)
Gene set enrichment analysis: a knowledge-based approach for interpreting
genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550.
79. Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative
analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:
44–57.
80. Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID:
Database for Annotation, Visualization, and Integrated Discovery. Genome Biol
4: P3.
81. Bryne JC, Valen E, Tang MH, Marstrand T, Winther O, et al. (2008) JASPAR,
the open access database of transcription factor-binding profiles: new content
and tools in the 2008 update. Nucleic Acids Res 36: D102–106.
82. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, et al. (2003)
TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids
Res 31: 374–378.
83. Frith MC, Fu Y, Yu L, Chen JF, Hansen U, et al. (2004) Detection of functional
DNA motifs via statistical over-representation. Nucleic Acids Res 32:
1372–1381.
84. Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, et al. (2005)
Dicer-deficient mouse embryonic stem cells are defective in differentiation and
centromeric silencing. Genes Dev 19: 489–501.
85. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D (2002) Germline transmission
and tissue-specific expression of transgenes delivered by lentiviral vectors.
Science 295: 868–872.
86. Chuck AS, Palsson BO (1996) Consistent and high rates of gene transfer can be
obtained using flow-through transduction over a wide range of retroviral titers.
Hum Gene Ther 7: 743–750.
87. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:
402–408.
88. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for
biologist programmers. Methods Mol Biol 132: 365–386.
89. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch’ng LE, et al. (1998) Gene dosage-
dependent embryonic development and proliferation defects in mice lacking the
transcriptional integrator p300. Cell 93: 361–372.
Role of CREBBP in Pre-mRNA Processing
PLoS ONE | www.plosone.org 14 August 2011 | Volume 6 | Issue 8 | e24153